Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine

被引:51
作者
Aizawa, S [1 ]
Ookawa, K [1 ]
Kudo, T [1 ]
Asano, J [1 ]
Hayakari, M [1 ]
Tsuchida, S [1 ]
机构
[1] Hirosaki Univ, Sch Med, Dept Biochem 2, Hirosaki, Aomori 0368562, Japan
关键词
D O I
10.1111/j.1349-7006.2003.tb01371.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since ethacrynic acid (EA), an SH modifier as well as glutathione S-transferase (GST) inhibitor, has been suggested to induce apoptosis in some cell lines, its effects on a human colon cancer cell line DLD-1 were examined. EA enhanced cell proliferation at 20-40 muM, while it caused cell death at 60-100 muM. Caspase inhibitors did not block cell death and DNA ladder formation was not detected. Poly(ADP-ribose) polymerase, however, was cleaved into an 82-kDa fragment, different from an 85-kDa fragment that is specific for apoptosisis. The 82-kDa fragment was not recognized by antibody against PARP fragment cleaved by caspase 3. N-Acetyl-L-cysteine (NAC) completely inhibited EA-induced cell death, but 3(2)-t-butyl-4-hydroxyanisole or pyrrolidinedithiocarbamate ammonium salt did not. Glutathione (GSH) levels were dose-dependently increased in cells treated with EA and this increase was hardly affected by NAC addition. Mitogen-activated protein kinase (MAPK) kinase (MEK) 1, extracellular signal-regulated kinase (ERK) 1 and GST P1-1 were increased in cells treated with 25-75 muM EA, while c-Jun N-terminal kinase (JNK) 1 and p38 MAPK were markedly decreased by 100 muM EA. NAC repressed EA-induced alterations in these MAPKs and GST P1-1. p38 MAPK inhibitors, SB203580 and FR167653, dose-dependently enhanced EA-induced cell death. An MEK inhibitor, U0126, did not affect EA-induced cell death. These studies revealed that EA induced cell death concomitantly with a novel PARP fragmentation, but without DNA fragmentation. p38 MAPK was suggested to play an inhibitory role in EA-induced cell death.
引用
收藏
页码:886 / 893
页数:8
相关论文
共 48 条
[1]   Regulation of JNK signaling by GSTp [J].
Adler, V ;
Yin, ZM ;
Fuchs, SY ;
Benezra, M ;
Rosario, L ;
Tew, KD ;
Pincus, MR ;
Sardana, M ;
Henderson, CJ ;
Wolf, CR ;
Davis, RJ ;
Ronai, Z .
EMBO JOURNAL, 1999, 18 (05) :1321-1334
[2]   A NEW RAPID AND SIMPLE NONRADIOACTIVE ASSAY TO MONITOR AND DETERMINE THE PROLIFERATION OF LYMPHOCYTES - AN ALTERNATIVE TO [H-3] THYMIDINE INCORPORATION ASSAY [J].
AHMED, SA ;
GOGAL, RM ;
WALSH, JE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :211-224
[3]   INHIBITION OF SOLUBLE GLUTATHIONE S-TRANSFERASE BY DIURETIC DRUGS [J].
AHOKAS, JT ;
DAVIES, C ;
RAVENSCROFT, PJ ;
EMMERSON, BT .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (12) :1929-1932
[4]  
Ban N, 1996, CANCER RES, V56, P3577
[5]  
BATIST G, 1986, J BIOL CHEM, V261, P5544
[6]   Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress [J].
Benhar, M ;
Dalyot, I ;
Engelberg, D ;
Levitzki, A .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (20) :6913-6926
[7]   Programmed cell death (PCD) -: Apoptosis, autophagic PCD, or others? [J].
Bursch, W ;
Ellinger, A ;
Gerner, C ;
Fröhwein, U ;
Schulte-Hermann, R .
MECHANISMS OF CELL DEATH II, 2000, 926 :1-12
[8]   Distinct cleavage products of nuclear proteins in apoptosis and necrosis revealed by autoantibody probes [J].
Casiano, CA ;
Ochs, RL ;
Tan, EM .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (02) :183-190
[9]   Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis [J].
Chen, YR ;
Meyer, CF ;
Tan, TH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :631-634
[10]   SELECTIVE ALTERATION OF ERYTHROCYTE DEFORMABILITY BY SH-REAGENTS - EVIDENCE FOR AN INVOLVEMENT OF SPECTRIN IN MEMBRANE SHEAR ELASTICITY [J].
FISCHER, TM ;
HAEST, CWM ;
STOHR, M ;
KAMP, D ;
DEUTICKE, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 510 (02) :270-282